Potent, practical medicated plaster with a uniform metered dose delivered directly to the affected area
Active Ingredients:
Betamethasone valerate 2.250 mg per 7.5 cm x 10 cm medicated plaster (corresponding to 1.845 mg of betamethasone)
A medicated corticosteroid plaster for the treatment of chronic, localised inflammatory skin disorders in adults.
Betesil® is indicated in adults for the treatment of inflammatory skin disorders which do not respond to treatment with less potent corticosteroids, such as eczema, lichenification, lichen planus, granuloma annulare, palmoplantar pustulosis and mycosis fungoides.
Due to its particular pharmaceutical form, Betesil® is suitable for chronic plaque psoriasis localized in difficult to treat areas (e.g. knees, elbows and anterior face of the tibia on an area not greater than 5% of the body surface).
Betesil® contains 2.250 mg Betamethasone Valerate (corresponding to 1.845 mg of betamethasone).
Betesil® provides a localised, uniform concentration of Betamethasone valerate(1)
Potent Action:
- Anti-inflammatory
- Anti-itch(5)
- Vasoconstrictive(5)
Advantages of Betesil® Medicated Plaster
- Helps deliver a more accurate dose of steroid due to its pharmaceutical form
- Protection of the lesion via a medicated plaster
- Superior efficacy versus Betamethasone cream(2)(3)
- Occlusive nature of dressing assists skin rehydration and healing
- Gentle adhesion to support minimal cell-stripping
- Efficacy equivalent to Calcipotriol-Betamethasone dipropionate (50 µg - 0.5mg/g) ointment(4)
- One month’s use after opening each plaster sachet.(1) Keep cutting down for multiple treatments per plaster
- Supplied with adhesive strips to secure the dressing if required
- Aluminium storage pouches ensure product integrity once open/cut(1)
Betesil® Application Guide Video
Watch our application guide video which provides some helpful advice for patients on how best to use Betesil®, including a variety of cutting and application techniques.
(For Healthcare Professionals and Patients)
For Healthcare Professionals
Arrange a Demonstration
Arrange a demonstration, this can be arranged either face to face within your department or digitally. (for healthcare professionals)
Betesil® Resources
Browse our latest product information and expert-led advice.
FAQs
How do I administer a Betesil® plaster?
Cleanse and carefully dry the area to be treated before each application so that the medicated plaster adheres well to the skin.
Furthermore, if the medicated plaster is applied to particularly mobile parts (e.g. an elbow or knee) and its edges start to lift, it is advisable to apply the adhesive strips for securing dressings included in the medicinal product pack.
Children aged <18 years
Do not use on patients under 18 years of age.
How often do I use Betesil® plaster?
1 plaster per plaque every 24 hours.
How many times can I use Betesil® plaster?
6 plasters/day maximum.
How do I secure the Betesil® plaster?
Adhesive strips included for securing dressings if required.
What pack sizes do Betesil® come in?
Betesil® comes in boxes of 4 and 8.
What’s in the Betesil® plaster pack?
Box of 4 or 8 medicated plasters (10 x 7.5 cm)
What is the maximum treatment?
30 days until plaque improves, then if needed continue treatment with a less potent corticosteroid
Additional Information
Betesil® product information
Betesil® contains 2.250 mg Betamethasone Valerate (corresponding to 1.845 mg of betamethasone).
Each medicated plaster is packed individually in a paper/polyethylene/aluminium/ethylene-methacrylic acid copolymer sachet.
Each box includes adhesive strips for securing dressings.
Betesil® Summary of Product Characteristics
The Summary of Product Characteristics, which may be downloaded below, is the most up to date version. Due to the timing of regulatory changes this may vary from the document on the MHRA website.
If you have any queries, please contact us on +44 (0)191 375 9020
Abbreviated prescribing information
Click the button below to view the Abbreviated prescribing information
Patient information leaflet
Below you will find a button to download the Betesil® Patient Information Leaflet.
If you have any queries, please contact us on +44 (0)191 375 9020
Active ingredients
Betamethasone valerate 2.250 mg per 7.5 cm x 10 cm medicated plaster
(corresponding to 1.845 mg of betamethasone)
Adverse Events
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk
Adverse events should also be reported to Derma UK on +44 (0)191 375 9020.
References
- Derma UK Ltd., ‘Summary of Betesil® Product Characteristics (SmPC).’ 2021
- Naldi L et al., ‘Efficacy and Safety of the Betamethasone Valerate 0,1% Plaster in Mild-to-Moderate Chronic Plaque Psoriasis: A Randomized, Parallel-Group, Active-Controlled, Phase III Study.’ American Journal of Clinical Dermatology, vol. 12, no 3, 2011, pp. 191-2011.
- Pacifico A et al., ‘A new formulation of an occlusive dressing containing betamethasone valerate 0.1% in the treatment of mild to moderate psoriasis.’ Journal of European Academy of Dermatology and Venereology, no 20, 2006, pp. 153-157.
- Ortonne JP, et al., ‘Betamethasone valerate dressing is non-inferior to calcipotriol-betamethasone dipropionate ointment in the treatment of patients with mild-to-moderate chronic plaque psoriasis: results of a randomized assessor-blinded multicentre trial.’ Journal of European Academy of Dermatology and Venereology, vol. 28, no 9, 2014, pp. 1226-34.
- National Institute for Health and Care Excellence, Topical corticosteroids, National Institute for Health and Care Excellence, https://bnf.nice.org.uk/treatment-summary/topical-corticosteroids.html, (accessed 24th November 2021).